Patent · US Active

Chimeric rabbit/human ROR1 antibodies

US9758586B2 · kind B2 · utility

13Cited by

2References

23Claims

0Family size

Assignee

The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Christoph Rader · San Diego, US
Jiahui Yang · 流花街道, CN

Key dates

Filing date	Nov 30, 2011
Grant date	Sep 12, 2017
Priority date	—
Expiry date	Nov 30, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to antibodies having specificity for human ROR1, compositions thereof, and methods for using such antibodies, including in the diagnosis and treatment of disorders associated with aberrant ROR1 expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.